Monday, April 10, 2023
12:06 PM EST – ProMIS Neurosciences Inc : Announced the submission of an Investigational New Drug application to the U.S. Food and Drug Administration (FDA) for PMN310 for the treatment of Alzheimer’s disease. ProMIS Neurosciences Inc (T.PMN) shares were unchanged at 6.75.
Stocks in Play: ProMIS Neurosciences Inc, Mon, 10 Apr 2023 12:12:07 EST